scispace - formally typeset
Open AccessJournal Article

Dimercaptosuccinic Acid (DMSA), A Non-Toxic, Water-Soluble Treatment For Heavy Metal Toxicity

Miller Al
- 01 Jun 1998 - 
- Vol. 3, Iss: 3, pp 199-207
Reads0
Chats0
TLDR
DMSA is a sulfhydryl-containing, water-soluble, non-toxic, orally-administered metal chelator which has been in use as an antidote to heavy metal toxicity since the 1950s and is established as the premier metal chelation compound, based on oral dosing, urinary excretion, and its safety characteristics compared to other chelating substances.
Abstract
Heavy metals are, unfortunately, present in the air, water, and food supply. Cases of severe acute lead, mercury, arsenic, and cadmium poisoning are rare; however, when they do occur an effective, non-toxic treatment is essential. In addition, chronic, low-level exposure to lead in the soil and in residues of lead-based paint; to mercury in the atmosphere, in dental amalgams and in seafood; and to cadmium and arsenic in the environment and in cigarette smoke is much more common than acute exposure. Meso-2,3-dimercaptosuccinic acid (DMSA) is a sulfhydryl-containing, water-soluble, non-toxic, orally-administered metal chelator which has been in use as an antidote to heavy metal toxicity since the 1950s. More recent clinical use and research substantiates this compound’s efficacy and safety, and establishes it as the premier metal chelation compound, based on oral dosing, urinary excretion, and its safety characteristics compared to other chelating substances. (Altern Med Rev 1998;3(3):199-207)

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Chelation in Metal Intoxication

TL;DR: This review provides an update of the existing chelating agents and the various strategies available for the treatment of heavy metals and metalloid intoxications.
Journal ArticleDOI

Removal of Heavy Metals from Aqueous Systems with Thiol Functionalized Superparamagnetic Nanoparticles

TL;DR: Superparamagnetic iron oxide (Fe3O4) nanoparticles with a surface functionalization of dimercaptosuccinic acid (DMSA) are an effective sorbent material for toxic soft metals such as Hg, Ag, Pb, Cd, and Tl, which effectively bind to the DMSA ligands and for As, which binds to the iron oxide lattices.
Journal ArticleDOI

Mercury exposure in children: a review.

TL;DR: Considerable attention was given in this review to pediatric methylmercury exposure and neurodevelopment because it is the most thoroughly investigated Hg species.
Journal Article

Cysteine metabolism and metal toxicity.

TL;DR: Basic research pertaining to the transport of toxic metals into the brain is summarized, and a case is made for the use of hydrolyzed whey protein to support metal detoxification and neurological function.
References
More filters
Journal Article

Neurobehavioral aspects of lead neurotoxicity in children.

TL;DR: Meter analyses on both cross sectional and prospective studies in lead exposed children have concluded that a typical doubling of PbB from 100 to 200 micrograms/l is associated with an average loss of IQ of 1-3 points.
Journal ArticleDOI

Effect of chelate treatments on kidney, bone and brain lead levels of lead-intoxicated mice.

TL;DR: An examination of published data describing the effect of chelating agent treatment onbrain lead levels indicates that DMSA produces a reduction in brain lead levels under all conditions examined to date.
Journal ArticleDOI

Mercury excretion and occupational exposure of dental personnel

TL;DR: The data indicate that urinary mercury excretion may be gender dependent and that the restorative status of the participants contribute to the daily mercury exposure, and that participants working in environments with wooden floors had significantly higher mean mercury values than other dental personnel.
Journal Article

Lead and the kidney: nephropathy, hypertension, and gout.

TL;DR: Treatment of chronic lead nephropathy with EDTA lead mobilization is useful if renal failure is modest; however, EDTA mobilization is of no benefit in patients with more severe renal insufficiency.
Related Papers (5)